Obstacles to improving outcomes in the treatment of uveal melanoma

被引：19
|
作者：
Tsai, Katy K. [1 ]
Bollin, Kathryn B. [2 ]
Patel, Sapna P. [3 ]
机构：
[1] Univ Calif San Francisco, Cutaneous Oncol, Hellen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] Scripps Clin, Div Hematol & Oncol, La Jolla, CA 92037 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源：
CANCER | 2018年 / 124卷 / 13期
基金：
美国国家卫生研究院;
关键词：
barriers; challenges; outcomes; success; therapy; treatment; trials; uveal melanoma; INTRAARTERIAL HEPATIC FOTEMUSTINE; DEPENDENT PROBE AMPLIFICATION; GENE-EXPRESSION PROFILE; LIVER METASTASES; CHOROIDAL MELANOMA; DOUBLE-BLIND; PROGNOSTIC IMPLICATIONS; UNTREATED MELANOMA; COMPLETE RESECTION; TUMOR DIAMETER;
D O I：
10.1002/cncr.31284
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The rate of advances in uveal melanoma has not kept pace with the rate of advances in cutaneous melanoma. Many patients lack access to or knowledge of specialty centers, and integrated multidisciplinary care between ophthalmology, radiation oncology, and medical oncology is far from the norm. This treatment isolation leads to limited communication about novel clinical trial opportunities. Clinical trials themselves are not widely available, and a lack of robust funding limits rapid and complete investigations. This review outlines the obstacles to success in uveal melanoma management and highlights strategies for overcoming these challenges. (C) 2018 American Cancer Society.
引用
收藏
页码：2693 / 2703
页数：11
相关论文
共 50 条
  • [41] New Treatment Horizons in Uveal and Cutaneous Melanoma
    Branisteanu, Daciana Elena
    Porumb-Andrese, Elena
    Porumb, Vlad
    Starica, Alexandra
    Moraru, Andreea Dana
    Nicolescu, Alin Codrut
    Zemba, Mihail
    Branisteanu, Catalina Ioana
    Branisteanu, George
    Branisteanu, Daniel Constantin
    LIFE-BASEL, 2023, 13 (08):
  • [42] Targeting of ERK and HDAC in the treatment of uveal melanoma
    Musi, Elgilda
    Dao, Kim-Hien
    Hindley, Chris
    Schwartz, Gary K.
    CANCER RESEARCH, 2022, 82 (12)
  • [43] METHODS FOR COMBINATION TREATMENT OF METASTATIC UVEAL MELANOMA
    Kolomiets, K., V
    Ponomareva, E. S.
    Posypina, Yar
    Mihailov, I. I.
    Mandzhiev, C. B.
    Povetkina, E., V
    Tuguz, R. R.
    Bulgakov, S. M.
    Repunova, V., I
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2023, (06): : 86 - 89
  • [44] A novel ERK inhibitor in the treatment of uveal melanoma
    Musi, Elgilda
    Ambrosini, Grazia
    Munck, Joanne
    Schwartz, Gary K.
    CANCER RESEARCH, 2018, 78 (13)
  • [45] UVEAL MELANOMA SURVIVAL AFTER RADIATION TREATMENT
    KROLL, S
    CHAR, DH
    QUIVEY, J
    OBRIEN, J
    CASTRO, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S494 - S494
  • [46] Delays in the diagnosis of uveal melanoma and effect on treatment
    Ah-Fat, FG
    Damato, BE
    EYE, 1998, 12 (5) : 781 - 782
  • [47] Treatment of metastatic uveal melanoma with intravenous fotemustine
    Spagnolo, Francesco
    Grosso, Marco
    Picasso, Virginia
    Tornari, Elena
    Pesce, Marianna
    Queirolo, Paola
    MELANOMA RESEARCH, 2013, 23 (03) : 196 - 198
  • [48] COMBINED TREATMENT OF UVEAL MELANOMA LIVER METASTASES
    Brasiuniene, B.
    Sokolovas, V.
    Brasiunas, V.
    Barakauskiene, A.
    Strupas, K.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 (02) : 71 - 75
  • [49] Diagnosis and treatment of orbital invasion in uveal melanoma
    Blanco, G
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2004, 39 (04): : 388 - 396
  • [50] Time to treatment of uveal melanoma in the United Kingdom
    Damato, B
    EYE, 2001, 15 (2) : 155 - 158
12345